Akero Therapeutics, Inc. (AKRO)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch AKRO
See up to 3 months of AKRO. The 7-day demo opens the 1M and 3M ranges and puts AKRO on your watchlist.
Start 7-day demoLatest AKRO insider trades
Andrew Cheng - OfficerOpen-market sale$1.62M
Timothy Rolph - OfficerOpen-market sale$527K
About Akero Therapeutics, Inc. (AKRO)
Akero Therapeutics, Inc. files with the SEC under CIK 0001744659 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
AKRO Form 4 activity by transaction type, last 90 days
No Form 4 activity for AKRO in the last 90 days.
AKRO insider transactions (Form 4)
7773 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Timothy Rolph - Officer | Option exercise | Common Stock | 7,044 | $21.09 | $149K | |
| Timothy Rolph - Officer | Option exercise | Common Stock | 5,161 | $6.36 | $33K | |
| Timothy Rolph - Officer | Option exercise | Common Stock | 295 | $28.35 | $8K | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 12,466 | $44.17 | $551K | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 34 | $44.88 | $2K | |
| Timothy Rolph - Officer | Option exercise | Stock Option (Right to Buy) | 7,044 | $0.00 | - | |
| Timothy Rolph - Officer | Option exercise | Stock Option (Right to Buy) | 295 | $0.00 | - | |
| Timothy Rolph - Officer | Option exercise | Stock Option (Right to Buy) | 5,161 | $0.00 | - | |
| Jonathan Young - Officer | Option exercise | Common Stock | 12,500 | $21.10 | $264K | |
| Jonathan Young - Officer | Open-market sale | Common Stock | 9,700 | $45.78 | $444K | |
| Jonathan Young - Officer | Open-market sale | Common Stock | 2,739 | $47.14 | $129K | |
| Jonathan Young - Officer | Open-market sale | Common Stock | 61 | $47.58 | $3K | |
| Jonathan Young - Officer | Option exercise | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Scott A. Gangloff - Officer | Option exercise | Common Stock | 2,600 | $19.62 | $51K | |
| Scott A. Gangloff - Officer | Option exercise | Stock option (Right to Buy) | 2,600 | $0.00 | - | |
| Jonathan Young - Officer | Option exercise | Common Stock | 12,500 | $21.10 | $264K | |
| Jonathan Young - Officer | Open-market sale | Common Stock | 11,151 | $47.72 | $532K | |
| Jonathan Young - Officer | Open-market sale | Common Stock | 1,349 | $48.32 | $65K | |
| Jonathan Young - Officer | Option exercise | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
 Jane Henderson | Option exercise | Common Stock | 3,000 | $7.01 | $21K | |
| Jane Henderson | Open-market sale | Common Stock | 3,000 | $47.46 | $142K | |
| Jane Henderson | Option exercise | Stock Option (Right to Buy) | 3,000 | $0.00 | - | |
| Andrew Cheng - Officer | Open-market sale | Common Stock | 10,795 | $48.07 | $519K | |
| Andrew Cheng - Officer | Open-market sale | Common Stock | 18,805 | $48.87 | $919K | |
| Andrew Cheng - Officer | Open-market sale | Common Stock | 400 | $49.44 | $20K | |
| Timothy Rolph - Officer | Option exercise | Common Stock | 12,500 | $21.09 | $264K | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 5,538 | $49.07 | $272K | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 6,962 | $49.49 | $345K | |
| Timothy Rolph - Officer | Option exercise | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
 Catriona Yale - Officer | Option exercise | Common Stock | 10,000 | $19.87 | $199K | |
| Catriona Yale - Officer | Open-market sale | Common Stock | 8,658 | $52.87 | $458K | |
| Catriona Yale - Officer | Open-market sale | Common Stock | 1,342 | $53.47 | $72K | |
| Catriona Yale - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Andrew Cheng - Officer | Open-market sale | Common Stock | 14,686 | $50.57 | $743K | |
| Andrew Cheng - Officer | Open-market sale | Common Stock | 15,314 | $51.73 | $792K | |
| Timothy Rolph - Officer | Option exercise | Common Stock | 12,500 | $21.09 | $264K | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 10,634 | $50.93 | $542K | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 1,825 | $52.00 | $95K | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 41 | $52.62 | $2K | |
| Timothy Rolph - Officer | Option exercise | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
 Patrick Lamy - Officer | Open-market sale | Common Stock | 2,000 | $52.88 | $106K | |
| Catriona Yale - Officer | Grant or award | Common Stock | 890 | $23.87 | $21K | |
| Jonathan Young - Officer | Grant or award | Common Stock | 890 | $23.87 | $21K | |
| Patrick Lamy - Officer | Grant or award | Common Stock | 193 | $23.87 | $5K | |
 William Richard White - Officer | Grant or award | Common Stock | 890 | $23.87 | $21K | |
| Timothy Rolph - Officer | Grant or award | Common Stock | 890 | $23.87 | $21K | |
| Andrew Cheng - Officer | Grant or award | Common Stock | 890 | $23.87 | $21K | |
| Scott A. Gangloff - Officer | Grant or award | Common Stock | 299 | $23.87 | $7K | |
| Timothy Rolph - Officer | Gift | Common Stock | 14,100 | $0.00 | - | |
| Jonathan Young - Officer | Grant or award | Common Stock | 24,300 | $0.00 | - | |
| Jonathan Young - Officer | Grant or award | Stock Option (Right to Buy) | 73,700 | $0.00 | - | |
| Patrick Lamy - Officer | Grant or award | Common Stock | 17,400 | $0.00 | - | |
| Patrick Lamy - Officer | Open-market sale | Common Stock | 1,000 | $29.13 | $29K | |
| Patrick Lamy - Officer | Grant or award | Stock Option (Right to Buy) | 52,100 | $0.00 | - | |
| Catriona Yale - Officer | Grant or award | Common Stock | 24,300 | $0.00 | - | |
| Catriona Yale - Officer | Option exercise | Common Stock | 9,074 | $21.10 | $191K | |
| Catriona Yale - Officer | Open-market sale | Common Stock | 9,074 | $29.11 | $264K | |
| Catriona Yale - Officer | Option exercise | Stock Option (Right to Buy) | 9,074 | $0.00 | - | |
| Catriona Yale - Officer | Grant or award | Stock Option (Right to Buy) | 73,700 | $0.00 | - | |
| William Richard White - Officer | Grant or award | Common Stock | 24,300 | $0.00 | - | |
| William Richard White - Officer | Grant or award | Stock Option (Right to Buy) | 73,700 | $0.00 | - | |
| Timothy Rolph - Officer | Option exercise | Common Stock | 3,800 | $19.87 | $76K | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 3,800 | $31.10 | $118K | |
| Timothy Rolph - Officer | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Timothy Rolph - Officer | Option exercise | Stock Option (Right to Buy) | 3,800 | $0.00 | - | |
| Timothy Rolph - Officer | Grant or award | Stock Option (Right to Buy) | 60,000 | $0.00 | - | |
| Andrew Cheng - Officer | Grant or award | Common Stock | 98,500 | $0.00 | - | |
| Andrew Cheng - Officer | Grant or award | Stock Option (Right to Buy) | 295,600 | $0.00 | - | |
| Scott A. Gangloff - Officer | Grant or award | Common Stock | 24,300 | $0.00 | - | |
| Scott A. Gangloff - Officer | Grant or award | Stock Option (Right to Buy) | 73,700 | $0.00 | - | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 2,368 | $30.79 | $73K | |
| Timothy Rolph - Officer | Option exercise | Common Stock | 2,450 | $19.87 | $49K | |
| Timothy Rolph - Officer | Open-market sale | Common Stock | 2,450 | $31.03 | $76K | |
| Timothy Rolph - Officer | Option exercise | Stock Option (Right to Buy) | 2,450 | $0.00 | - | |
| Jonathan Young - Officer | Open-market sale | Common Stock | 2,503 | $30.79 | $77K | |
| Patrick Lamy - Officer | Open-market sale | Common Stock | 925 | $30.79 | $28K | |
| Catriona Yale - Officer | Open-market sale | Common Stock | 2,810 | $30.79 | $87K |
AKRO insider trading FAQ
What is the latest insider trade for AKRO?
Akero Therapeutics, Inc. (AKRO) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-12-09. The full record for AKRO runs to 73 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AKRO stock?
No insider purchases of AKRO were filed in the last 90 days.
How many insiders are selling AKRO stock?
No insider sales of AKRO were filed in the last 90 days. 65 sales are on record for this company.
Where can I see AKRO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AKRO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Tomas J. Heyman view on EDGAR
- - Yuan Xu view on EDGAR
- - Andrew Cheng view on EDGAR
- - Seth Loring Harrison view on EDGAR
- - G. Walmsley Graham view on EDGAR
- - Chou Judy view on EDGAR
- - Timothy Rolph view on EDGAR
- - Mark T. Iwicki view on EDGAR
- - Scott A. Gangloff view on EDGAR
- - William Richard White view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AKRO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AKRO with a 7-day demo
- AKRO on your watchlist
- Every AKRO Form 4 filing on record
- Up to 3 months of AKRO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
